Physicochemical and biological evaluation of JR-131 as a biosimilar to a long-acting erythropoiesis-stimulating agent darbepoetin alfa

Renal anemia is predominantly caused by a relative deficiency in erythropoietin (EPO). Conventional treatment for renal anemia includes the use of recombinant human EPO (rhEPO) or a long-acting erythropoiesis-activating agent named darbepoetin alfa, which is a modified rhEPO with a carbohydrate chai...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Junya, Ito, Yae, Tatemichi, Satoshi, Yamakami, Makoto, Fukui, Tsuyoshi, Hatano, Yukichi, Kakimoto, Shinji, Kotani, Ayaka, Sugimura, Atsushi, Mihara, Kazutoshi, Yamamoto, Ryuji, Tanaka, Noboru, Minami, Kohtaro, Takahashi, Kenichi, Hirato, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164597/
https://www.ncbi.nlm.nih.gov/pubmed/32302352
http://dx.doi.org/10.1371/journal.pone.0231830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164597/
https://www.ncbi.nlm.nih.gov/pubmed/32302352
http://dx.doi.org/10.1371/journal.pone.0231830

Ejemplares similares